Search research articles
Contact Us
Filters
Showing results (31-40 of 95) with videos related to
Page
of 10
Sort By:
Current Treatment Options in Gastroenterology
|
January 6, 2020
Current Endpoints of Clinical Trials in Ulcerative Colitis: Are They Valid?
Robert Battat, Parambir S Dulai, Christopher Ma, et al.
Frontiers in Medicine
|
January 10, 2022
Relationship Between Patient Sex and Serum Tumor Necrosis Factor Antagonist Drug and Anti-drug Antibody Concentrations in Inflammatory Bowel Disease; A Nationwide Cohort Study
Mohammad Shehab, Hajer Alasfour, Israa Abdullah, et al.
World Journal of Gastroenterology
|
September 26, 2022
Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease
Benjamin Langan Gordon, Jonathan S Galati, Stevie Yang, et al.
Inflammatory Bowel Diseases
|
March 31, 2025
The Impact of Endoscopic Healing on Disease-Related Outcomes in Patients With Ulcerative Proctitis
Esther Y Liu, Anjile An, Shaira Khan, et al.
Inflammatory Bowel Diseases
|
November 24, 2022
Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease
Kaylie Chen, Johnson Chen, Emily Smith, et al.
Drugs
|
July 19, 2019
Innovations in Oral Therapies for Inflammatory Bowel Disease
Christopher Ma, Robert Battat, Parambir S Dulai, et al.
Digestive Diseases and Sciences
|
October 22, 2020
Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases
Andres J Yarur, Parakkal Deepak, Niels Vande Casteele, et al.
Journal of Crohn'S & Colitis
|
October 30, 2018
Reply to Letter on: 'Risk Factors Associated With Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis'
Bhairavi Balram, Robert Battat, Alex Al-Khoury, et al.
Inflammatory Bowel Diseases
|
February 25, 2022
Utility of Therapeutic Drug Monitoring for Tumor Necrosis Factor Antagonists and Ustekinumab in Postoperative Crohn's Disease
Yushan Pan, Waseem Ahmed, Prerna Mahtani, et al.
Crohn'S & Colitis 360
|
April 5, 2023
The Impact of Confounders on Symptom-Endoscopic Discordances in Crohn's Disease
Anjana Rajan, Yushan Pan, Prerna Mahtani, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 95) with videos related to
Sort By:
Page
of 10
Current Treatment Options in Gastroenterology
|
January 6, 2020
Current Endpoints of Clinical Trials in Ulcerative Colitis: Are They Valid?
Robert Battat, Parambir S Dulai, Christopher Ma, et al.
Frontiers in Medicine
|
January 10, 2022
Relationship Between Patient Sex and Serum Tumor Necrosis Factor Antagonist Drug and Anti-drug Antibody Concentrations in Inflammatory Bowel Disease; A Nationwide Cohort Study
Mohammad Shehab, Hajer Alasfour, Israa Abdullah, et al.
World Journal of Gastroenterology
|
September 26, 2022
Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease
Benjamin Langan Gordon, Jonathan S Galati, Stevie Yang, et al.
Inflammatory Bowel Diseases
|
March 31, 2025
The Impact of Endoscopic Healing on Disease-Related Outcomes in Patients With Ulcerative Proctitis
Esther Y Liu, Anjile An, Shaira Khan, et al.
Inflammatory Bowel Diseases
|
November 24, 2022
Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease
Kaylie Chen, Johnson Chen, Emily Smith, et al.
Drugs
|
July 19, 2019
Innovations in Oral Therapies for Inflammatory Bowel Disease
Christopher Ma, Robert Battat, Parambir S Dulai, et al.
Digestive Diseases and Sciences
|
October 22, 2020
Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases
Andres J Yarur, Parakkal Deepak, Niels Vande Casteele, et al.
Journal of Crohn'S & Colitis
|
October 30, 2018
Reply to Letter on: 'Risk Factors Associated With Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis'
Bhairavi Balram, Robert Battat, Alex Al-Khoury, et al.
Inflammatory Bowel Diseases
|
February 25, 2022
Utility of Therapeutic Drug Monitoring for Tumor Necrosis Factor Antagonists and Ustekinumab in Postoperative Crohn's Disease
Yushan Pan, Waseem Ahmed, Prerna Mahtani, et al.
Crohn'S & Colitis 360
|
April 5, 2023
The Impact of Confounders on Symptom-Endoscopic Discordances in Crohn's Disease
Anjana Rajan, Yushan Pan, Prerna Mahtani, et al.
Page
of 10